Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after (177)Lu-PSMA-617 Radioligand Therapy

Background: Dosimetry can tailor prostate-specific membrane-antigen-targeted radioligand therapy (PSMA-RLT) for metastatic castration-resistant prostate cancer (mCRPC). However, whole-body tumor dosimetry is challenging in patients with a high tumor burden. We evaluate a simplified index-lesion-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Völter, Friederike, Mittlmeier, Lena, Gosewisch, Astrid, Brosch-Lenz, Julia, Gildehaus, Franz Josef, Zacherl, Mathias Johannes, Beyer, Leonie, Stief, Christian G., Holzgreve, Adrien, Rübenthaler, Johannes, Cyran, Clemens C., Böning, Guido, Bartenstein, Peter, Todica, Andrei, Ilhan, Harun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999994/
https://www.ncbi.nlm.nih.gov/pubmed/33802417
http://dx.doi.org/10.3390/diagnostics11030428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999994/
https://www.ncbi.nlm.nih.gov/pubmed/33802417
http://dx.doi.org/10.3390/diagnostics11030428

Ejemplares similares